Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher
Conflicts of Interest
Editorial Policies
Publication Ethics
Nickan Research Institute policy
DISCLAIMER
Open Access
Journal Issues
Current Issue
In Press
Archive
Guidelines
For Authors
For Authors-New
For Reviewers
Peer Review Process in JRIP
Peer Review Process flowchart in JRIP
Authors agreement form
Checklist for review
Editorial Workflow
Publication Ethics and Malpractice Statement
Human and animal right
Informed Consent
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Aims and Scope
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
J Renal Inj Prev
. 2017;6(1): 61-64. doi:
10.15171/jrip.2017.11
PMID:
28487874
PMCID:
PMC5414521
Original Article
Administration of pentoxifylline to improve anemia of hemodialysis patients
Heshmatolah Shahbazian
1
, Ali Ghorbani
1
, Azita Zafar-Mohtashami
2
* , Abdolreza Balali
3
, Armaghan AleAli
1
, Gholam Reza Lashkarara
4
Cited by CrossRef: 1
1- COŞKUN D, ÇETİN G, ÇORUM O. Keçilere Artan Dozlarda Pentoksifilin Uygulamasının Biyokimyasal ve Hematolojik Parametrelere Etkisi. 2022;
[Crossref]
2- Zakaria H, Hamdy N, Sayed-Ahmed N, El-Mallah A. Pentoxifylline improves anemia through its novel effect on hypoxia-inducible factor-2 alpha in hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial.
Postgraduate Medicine
. 2024;136(8):847
[Crossref]